 regress left ventricular hypertrophi partial correct anemia erythropoietin patient hemodialysi prospect studi myocardi effect recombin human erythropoietin rhepo treatment hemodialysi HD patient sever anemia hematocrit Ht echocardiograph studi midweek HD session year rhepo end studi period Ht cardiac index vs left ventricular mass index lvmi rhepo vs decreas concomit decreas LV end-diastol diamet vs cm interventricular septum thick ivst vs cm LV wall thick lvpwt vs cm patient hypertens hypotens drug group normotens group II lvmi group group II rhepo vs rhepo group lvmi group group II end studi vs elev ivst/lvpwt year rhepo vs correct asymmetr septal hypertrophi ventricular hypertrophi lvh regress partial correct anemia rhepo previou hypertens current need antihypertens treatment signific effect develop lvh whether regress outcom HD patient